Aburano T, Yokoyama K, Shuke N, Kinuya S, Takayama T, Tonami N, Hisada K
Department of Nuclear Medicine, Kanazawa University Hospital, Japan.
Clin Nucl Med. 1991 Jan;16(1):4-9. doi: 10.1097/00003072-199101000-00002.
To assess the presence of primary biliary cirrhosis, 15 patients at various histopathologic stages were studied by Tc-99m IDA hepatobiliary and/or Tc-99m colloid hepatic imaging. In the earlier stages (I and II), seven of eight patients (88%) showed uniform hepatic retention of Tc-99m IDA. Of seven patients in the same stage, however, four (57%) showed no abnormality on Tc-99m colliod imaging. In three of these four negative patients (75%), uniform hepatic retention of Tc-99m IDA was noted. In the later stages (III and IV), all seven patients showed decreased clearance with or without delayed tracer appearance in the intestine and prominent hepatic retention on Tc-99m IDA imaging; with Tc-99m colloid imaging there was enlargement of the spleen and increased activity in the spleen and bone marrow. Thus, Tc-99m IDA imaging is considered to be more useful in revealing this functional disorder at the earlier stage of primary biliary cirrhosis and in evaluating progression from an earlier to a later stage of disease. Tc-99m colloid imaging also effectively evaluated progression.
为评估原发性胆汁性肝硬化的存在情况,我们通过99m锝亚氨基二乙酸肝胆显像和/或99m锝胶体肝显像对15例处于不同组织病理学阶段的患者进行了研究。在早期阶段(I期和II期),8例患者中有7例(88%)表现为99m锝亚氨基二乙酸在肝脏均匀滞留。然而,在同一阶段的7例患者中,4例(57%)的99m锝胶体显像未显示异常。在这4例阴性患者中的3例(75%),观察到99m锝亚氨基二乙酸在肝脏均匀滞留。在后期阶段(III期和IV期),所有7例患者在99m锝亚氨基二乙酸显像中均显示清除率降低,伴有或不伴有肠道放射性示踪剂延迟出现以及肝脏明显滞留;99m锝胶体显像显示脾脏增大,脾脏和骨髓活性增加。因此,99m锝亚氨基二乙酸显像被认为在原发性胆汁性肝硬化早期揭示这种功能障碍以及评估疾病从早期到后期的进展方面更有用。99m锝胶体显像也能有效评估疾病进展。